Inventor · disambiguated record
Matthew F. Wipperman
Also filed as: WIPPERMAN MATTHEW · WIPPERMAN MATTHEW F
1 granted patent·10 pending applications·0 citations·filing 2021–2025
13Inventor score
Files withREGENERON PHARMA11
Top patents by PatentIndex Score
11 records- 0162US2024379195A1Systems and methods for reducing sample sizesREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0257US2023416349A1Methods Of Identifying And Evaluating Cat Allergy Gene Signatures In A Subject By Determining A Stratified Score Based On Gene ExpressionREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0356US2023340601A1Transcriptome Analysis For Treating InflammationREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0456US2025255516A1Gait analysis systemREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0555US2025025067A1Systems and methods for motor assessmentREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0654US2023193392A1Methods Of Identifying And Evaluating Liver Inflammation And Liver Fibrosis In A Subject By Determining A Stratified Score Based On Gene ExpressionREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0750US2024062906A1Systems and methods for test device analysisREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0849US12310717B2Gait analysis systemREGENERON PHARMA·Filed 2021·Granted May 27, 2025·0 cites·19 claims
- 0947US2025292907A1Systems and methods for performing gait and speech assessment associated with a disease stateREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 1045US2024248301A1Systems and methods for mobile and static biometric movement trackingREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1139US2022199245A1Systems and methods for signal based feature analysis to determine clinical outcomesREGENERON PHARMA·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →